GFACX
Price
$73.86
Change
-$0.24 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
OPTIX
Price
$115.43
Change
+$1.19 (+1.04%)
Updated
Jun 2 closing price
Net Assets
6.37B
Interact to see
Advertisement

GFACX vs OPTIX

Header iconGFACX vs OPTIX Comparison
Open Charts GFACX vs OPTIXBanner chart's image
GFACX vs OPTIX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. OPTIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and OPTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. OPTIX (6.37B). GFACX (0.00) and OPTIX (0.00) have matching dividends . GFACX was incepted earlier than OPTIX: GFACX (25 years) vs OPTIX (14 years). GFACX (1.35) is less costly to investors than OPTIX (0.63). OPTIX is a more actively managed with annual turnover of: 63.00 vs. GFACX (32.00). GFACX has a lower initial minimum investment than OPTIX: GFACX (250) vs OPTIX (1000000). OPTIX annual gain was more profitable for investors over the last year : 14.48 vs. GFACX (12.09). OPTIX return over 5 years is better than : 29.60 vs. GFACX (14.79).
GFACXOPTIXGFACX / OPTIX
Total Expense Ratio1.350.63214%
Annual Report Gross Expense Ratio1.350.63214%
Fund Existence25 years14 years-
Gain YTD10.10410.20699%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets338B6.37B5,309%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.0914.4883%
Returns for 3 years44.3669.9563%
Returns for 5 years14.7929.6050%
Returns for 10 years88.17109.8480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVLY33.800.92
+2.80%
Oak Valley Bancorp (CA)
PDD88.180.94
+1.08%
PDD Holdings
URBN72.260.74
+1.03%
Urban Outfitters
BAFN5.82-0.09
-1.52%
BayFirst Financial Corp
BCAX19.63-0.99
-4.80%
Bicara Therapeutics Inc.